Telehealth & Digital Health

As overdose deaths skyrocket among Black and Indigenous communities, a new webinar confronts the systemic failures and charts a course for equitable care.

Amid crushing financial pressures, one company is rewriting the playbook for medical revenue. Omega Healthcare's dual 'Leader' and 'Star Performer' status isn't just an award—it's a signal of a seismic shift powered by intelligent AI.

With a novel FDA clearance for its at-home UVB device, Solius Labs isn't just launching a product; it's creating a new market for personalized medicine.

Hearst and NYU Langone's star-studded Health Lab reveals a strategic pivot from fitness to holistic wellness, tapping a new market of longevity and vulnerability.

As patients turn to AI for health advice, a new peer-reviewed framework from Included Health offers a clinically-governed model for safety and trust.

A groundbreaking partnership turns millions of registered organ donors into potential living kidney donors, tackling a waitlist of 90,000 with one simple step.

Clear Health's Isoclear offers the power of isotretinoin without oral Accutane's strict rules, but its non-FDA-approved status raises critical questions.

Chronic fatigue, anxiety, and burnout are surging. A new wave of data-driven, integrative medicine claims to have the answer, moving beyond symptoms to the root cause.

GORGIE's new Rocket Pop flavor isn't just a drink; it's a strategic play in the booming wellness-energy market. Can nostalgia redefine a category?

A new partnership between Medventions and Mitacs aims to fix Canada's innovation gap by embedding engineers directly into clinics. Here's how it works.

A new report reveals AI overwhelmingly trusts academic hospitals, leaving major chains behind. What does this mean for patient choice and the future of healthcare?

Belmont Medical's acquisition of Arcos fuses life-saving devices with smart software, promising a new era of data-driven care for trauma and burn patients.

A Dutch medtech firm is advancing a pivotal study for its VCFix® system, a device that aims to reconstruct vertebrae rather than just fill them.

A key update to a revolutionary cancer therapy reduces post-treatment restrictions, signaling a new era of patient-centric care and system efficiency in Canada.

With a history of beating expectations and a flurry of strategic moves, Quest Diagnostics' July 23rd earnings report is a key vital sign for the entire diagnostics sector.

Humana secures a massive Illinois Medicaid contract, expanding its reach statewide. This strategic move signals a major shift towards whole-person care.

Heart + Paw is ditching one-size-fits-all pet care, betting on vet-guided personalization. Is this tech-driven approach the future of the industry?

With a key regulatory win in the UAE, WAT Medical is set to introduce its drug-free neuromodulation devices to a booming Middle Eastern healthcare market.

As giants rule the obesity market, small-cap MetaVia pitches a novel dual-agonist and a first-in-class MASH drug. Can its science win the day?

A landmark grant and trial expansion signal a pivotal shift in Parkinson's research, blending genetic targeting, global collaboration, and digital health.